Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | CDC25B | P30305 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | CHAT | P28329 | 1/20 | 0.32 |
| ▸ | SNCA | P37840 | 1/20 | 0.32 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
| ▸ | ACP1 | P24666 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21699686 | 0.81 | ALDH1A1 (0.42) | ALDH1A1CYP3A4HPGDHSD17B10TP53 | |
| SCHEMBL12433896 | 0.80 | GSTP1 (0.35) | ALDH1A1CYP3A4HPGDHSD17B10TP53 | |
| SCHEMBL18174842 | 0.80 | GSTP1 (0.35) | ALDH1A1CYP3A4HPGDHSD17B10TP53 | |
| SCHEMBL75981 | 0.80 | ALDH1A1 (0.38) | ALDH1A1CYP3A4HPGDHSD17B10TP53 | |
| SCHEMBL10028989 | 0.79 | GSTP1 (0.30) | — | |
| SCHEMBL557046 | 0.79 | GSTP1 (0.30) | — | |
| SCHEMBL18174851 | 0.78 | CYP1A2 (0.39) | ALDH1A1CYP3A4HPGDHSD17B10TP53 | |
| SCHEMBL18174852 | 0.78 | CYP1A2 (0.41) | ALDH1A1CYP3A4HPGDHSD17B10TP53 | |
| SCHEMBL17264045 | 0.77 | GSTP1 (0.31) | ALDH1A1CYP3A4 | |
| SCHEMBL10028986 | 0.77 | GSTP1 (0.31) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586211-B2 | Asymmetrical aryl amine derivative for organic electroluminescence devices, method for preparing same, organic thin film for organic electroluminescence devices and organic electroluminescence device using same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2013-11-19 | — | — | US | disclosed |
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | AOC2, ALKBH2, ALKBH1 | ALDH1A1 122/4885CYP3A4 1317/4885HPGD 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.